A National Cancer Institute-designated Comprehensive Cancer Center

Make an appointment: 800-826-HOPE
Hematologic Cancers Bookmark and Share

Hematologic Cancers

Hematologic cancers are those cancers that occur in cells of the immune system or in blood-forming tissues including bone marrow. As a pioneer in advancing care for all hematologic cancers and related blood disorders, City of Hope's Hematologic Malignancies and Stem Cell Transplantation Institute leads the field as one of the largest and most successful transplant centers in the world.
 
Led by Stephen J. Forman, M.D., Francis & Kathleen McNamara Distinguished Chair in Hematology and Hematopoietic Cell Transplantation, our dedicated, multidisciplinary team of health care professionals combine innovative research discoveries with superior clinical treatments to improve outcomes for patients with:
 
  • Leukemia (cancer of the blood cells)
    • Acute myeloid leukemia
    • Acute lymphoblastic leukemia
    • Chronic myelogenous leukemia
    • Chronic lymphocytic leukemia
  • Lymphoma (cancer of the lymphatic cells)
    • Hodgkin lymphoma
    • Non-Hodgkin lymphoma
  • Myeloma (cancer of plasma cells)
  • Myelodysplastic Syndrome  (serious blood abnormalities that can lead to cancer)
  • Other hematologic disorders
 
 
  • The Center for International Blood and Marrow Transplant Research Center has ranked City of Hope as an “over-performing” transplant center, and City of Hope is the only U.S. transplant center with this recognition for nine consecutive years.
  • City of Hope recognizes the importance of maintaining contact with all transplant patients to ensure they have optimal outcomes after their treatment have concluded. Established in 1998, our Long-term Follow-up Program follows all patients who have received a transplant at City of Hope. Through this program, our survivors can be carefully monitored for long-term effects and given timely interventions, while our clinicians and researchers have access to data that can be used to further improve cancer treatments.
  • City of Hope's hematology malignancy program integrates both transplant and non-transplant therapies, so there is a smoother transition of treatments for patients who ultimately need a stem cell transplant.
  • City of Hope physicians have extensive experience performing a wide variety of transplant procedures, having performed more than 12,000 transplants—one of the biggest programs in the United States. Our expertise includes both autologous and allogeneic stem cell transplants (using cells directly from the patient and from another person, respectively) and transplants using cells derived from bone marrow, peripheral blood and cord blood.
  • City of Hope’s transplant program is accredited by the Foundation for the Accreditation of Cellular Therapy (FACT), the standard of excellence for blood and bone marrow transplant programs in the United States.
 

As a Comprehensive Cancer Center designated by the National Cancer Institute, City of Hope is recognized as a leader in cancer treatment, research and education.  Patients at City of Hope have access to innovative clinical trials and nationally recognized experts who are developing novel, more effective methods for treating hematologic cancers and disorders.

Whether newly diagnosed or relapsed, City of Hope patients are cared for by a multidisciplinary team of health care professionals, including:
 
  • Hematologists
  • Medical oncologists
  • Radiation oncologists
  • Nurses
  • Pharmacists
  • Dieticians
  • Social workers
  • Psychiatrists
  • Psychologists
  • Patient Navigators
  • Chaplains
  • Supportive Care Specialists
 
Together, the patient care team collaborates to design and create integrated, individualized treatment plans using the most promising therapies and up-to-date clinical guidelines to ensure optimal outcomes for patients and their loved ones.
 

If you have been diagnosed with a hematologic cancer or are looking for a second opinion consultation about your treatment, find out more about becoming a patient or contact us at 800-826-HOPE.
 

Hematologic Cancers/HCT Team

Research and Clinical Trials

City of Hope is recognized internationally for its breakthrough research discoveries and clinical trials for developing new ways to treat hematologic cancers. Patients at City of Hope will have the ability to enroll in these trials, which can expand their treatment options and improve their outcomes.
 
Highlights of our current efforts include:
 
  • While stem cell transplants can be a lifesaving procedure for patients with hematologic disorders, it also carries a risk of graft versus host disease (GvHD), in which the newly transplanted stem cells do not recognize the recipient’s body as their own and start producing an immune response against it, leading to chronic and potentially serious complications. To reduce the likelihood of GvHD and to improve transplant outcomes, City of Hope is researching new ways to classify and match stem cell donors and recipients.
  • Harnessing the patient’s own immune system against the cancer, specifically through T-cell modification. In this experimental therapy, the patient’s own T-cells are extracted from the body, modified to recognize and attack cancer cells and re-infused back into the patient. This treatment has shown positive results for patients with lymphoma and lymphoid leukemia and is currently being studied for its potential against myeloid leukemia and multiple myeloma .
  • Our use and refinement of nonmyeloablative (“mini”) transplants, which relies less on the heavy doses of chemotherapy and radiation and more on the anti-cancer effects of the transplant itself. This novel approach allows otherwise ineligible patients, such as older patients or those who cannot tolerate radiation/chemotherapy-related effects, to be treated with this lifesaving procedure.
  • Continual development and improvement of drug regimens to treat hematologic cancers. Recently, City of Hope had led a national study of the drug brentuximab in patients with relapsed Hodgkin lymphoma , in whom the drug produced a high rate of response compared to standard therapy.
  • Our scientists are currently investigating leukemia stem cells, which several studies have suggested to cause leukemia. By identifying and eradicating these cancerous stem cells — instead of just the mature leukemia cells that conventional therapies target — a definitive cure for this disease can be achieved. 
 
 
 
If you have been diagnosed with a hematologic cancer or are looking for a second opinion consultation about your treatment, find out more about becoming a patient or contact us at 800-826-HOPE.
 

Living with a Hematologic Cancer

City of Hope patients have access to the broad range of services offered by our Department of Supportive Care Medicine. The department’s staff of professionals can give expert assistance in navigating a complex care as well as helping patients and loved ones with a variety of wellness issues including:
 
  • Managing side effects
  • Pain management
  • Coping and maintaining emotional/social/spiritual well-being
  • Staying healthy and active during/after treatment
  • Guidance on eating well and cooking smart
  • Healing arts
  • Being active
  • Building caregivers’ skills
  • Sexual health and fertility
  • Body image
 
 
The Sheri & Les Biller Patient and Family Resource Center is the heart of the Department of Supportive Care Medicine, integrating City of Hope's support services under one umbrella. The Biller Resource Center provides a warm and welcoming space where patients, families and caregivers can access the resources, education and support they need to strengthen and empower themselves, before, during and after treatment.

Our team of supportive care experts includes clinical social workers; pain and palliative care physicians and nurses; psychologists, psychiatrists; patient navigators; health educators; spiritual care chaplains; child life specialists and more. The Biller Resource Center staff may be reached at 626-256-4673, ext. 32273 (3CARE).
 
 
Here you will find tips, tools and resources to help you and your family cope with the issues that arise during and after cancer treatment.
 
Other Resources
 
"A Patient's Guide to Blood and Marrow Stem Cell Transplantation at City of Hope" was developed to help City of Hope patients and their families learn about blood and marrow transplantation and what to expect before, during and after transplant at City of Hope.
 
 

If you have been diagnosed with a hematologic cancer or are looking for a second opinion consultation about your treatment, find out more about becoming a patient or contact us at 800-826-HOPE.

Celebration of Life Bone Marrow Transplant/HCT Reunion

Bone marrow transplants offer a second chance for people with life-threatening blood cancers and other hematologic malignancies.  City of Hope performed its first bone marrow transplant in 1976. Since then, thousands of patients from virtually every state and dozens of countries have undergone bone marrow, cord blood or stem cell transplants at City of Hope.

City of Hope invites bone marrow transplant recipients and their families to attend the annual “Celebration of Life" event on the Duarte campus. The reunion has grown to more than 6,500 attendees from all over the United States and overseas. The reunion is a joyous day for everyone in attendance — physicians, nurses and former patients — as they celebrate the victories they have attained in fighting cancer. The day also features performances by former patients who entertain their fellow survivors and their families.

The patient-donor meeting is an emotional highlight of the event. Recipients, though overwhelmed with curiosity and the need to express their gratitude, can only dream of meeting the strangers who saved their lives. City of Hope makes that dream come true for two patients every year.

Watch videos, view pictures, read stories and learn more about the Celebration of Life Bone Marrow Transplant Reunion:
 
 
The annual reunion also enables physicians and researchers to advance the science of stem cell transplantation through the sharing of the findings and advances at the Karl G. Blume-Gerhard Schmidt Memorial Lecture held in conjunction with the reunion. The event commemorates the work and dedication of the late Gerhard Schmidt, M.D., who joined City of Hope's hematology program in 1977 and has made numerous contributions to the field throughout this career.
 
 
 
 
 

Hematologic Cancers

Hematologic Cancers

Hematologic cancers are those cancers that occur in cells of the immune system or in blood-forming tissues including bone marrow. As a pioneer in advancing care for all hematologic cancers and related blood disorders, City of Hope's Hematologic Malignancies and Stem Cell Transplantation Institute leads the field as one of the largest and most successful transplant centers in the world.
 
Led by Stephen J. Forman, M.D., Francis & Kathleen McNamara Distinguished Chair in Hematology and Hematopoietic Cell Transplantation, our dedicated, multidisciplinary team of health care professionals combine innovative research discoveries with superior clinical treatments to improve outcomes for patients with:
 
  • Leukemia (cancer of the blood cells)
    • Acute myeloid leukemia
    • Acute lymphoblastic leukemia
    • Chronic myelogenous leukemia
    • Chronic lymphocytic leukemia
  • Lymphoma (cancer of the lymphatic cells)
    • Hodgkin lymphoma
    • Non-Hodgkin lymphoma
  • Myeloma (cancer of plasma cells)
  • Myelodysplastic Syndrome  (serious blood abnormalities that can lead to cancer)
  • Other hematologic disorders
 
 
  • The Center for International Blood and Marrow Transplant Research Center has ranked City of Hope as an “over-performing” transplant center, and City of Hope is the only U.S. transplant center with this recognition for nine consecutive years.
  • City of Hope recognizes the importance of maintaining contact with all transplant patients to ensure they have optimal outcomes after their treatment have concluded. Established in 1998, our Long-term Follow-up Program follows all patients who have received a transplant at City of Hope. Through this program, our survivors can be carefully monitored for long-term effects and given timely interventions, while our clinicians and researchers have access to data that can be used to further improve cancer treatments.
  • City of Hope's hematology malignancy program integrates both transplant and non-transplant therapies, so there is a smoother transition of treatments for patients who ultimately need a stem cell transplant.
  • City of Hope physicians have extensive experience performing a wide variety of transplant procedures, having performed more than 12,000 transplants—one of the biggest programs in the United States. Our expertise includes both autologous and allogeneic stem cell transplants (using cells directly from the patient and from another person, respectively) and transplants using cells derived from bone marrow, peripheral blood and cord blood.
  • City of Hope’s transplant program is accredited by the Foundation for the Accreditation of Cellular Therapy (FACT), the standard of excellence for blood and bone marrow transplant programs in the United States.
 

As a Comprehensive Cancer Center designated by the National Cancer Institute, City of Hope is recognized as a leader in cancer treatment, research and education.  Patients at City of Hope have access to innovative clinical trials and nationally recognized experts who are developing novel, more effective methods for treating hematologic cancers and disorders.

Whether newly diagnosed or relapsed, City of Hope patients are cared for by a multidisciplinary team of health care professionals, including:
 
  • Hematologists
  • Medical oncologists
  • Radiation oncologists
  • Nurses
  • Pharmacists
  • Dieticians
  • Social workers
  • Psychiatrists
  • Psychologists
  • Patient Navigators
  • Chaplains
  • Supportive Care Specialists
 
Together, the patient care team collaborates to design and create integrated, individualized treatment plans using the most promising therapies and up-to-date clinical guidelines to ensure optimal outcomes for patients and their loved ones.
 

If you have been diagnosed with a hematologic cancer or are looking for a second opinion consultation about your treatment, find out more about becoming a patient or contact us at 800-826-HOPE.
 

Hematologic Cancers Team

Hematologic Cancers/HCT Team

Research / Clinical Trials

Research and Clinical Trials

City of Hope is recognized internationally for its breakthrough research discoveries and clinical trials for developing new ways to treat hematologic cancers. Patients at City of Hope will have the ability to enroll in these trials, which can expand their treatment options and improve their outcomes.
 
Highlights of our current efforts include:
 
  • While stem cell transplants can be a lifesaving procedure for patients with hematologic disorders, it also carries a risk of graft versus host disease (GvHD), in which the newly transplanted stem cells do not recognize the recipient’s body as their own and start producing an immune response against it, leading to chronic and potentially serious complications. To reduce the likelihood of GvHD and to improve transplant outcomes, City of Hope is researching new ways to classify and match stem cell donors and recipients.
  • Harnessing the patient’s own immune system against the cancer, specifically through T-cell modification. In this experimental therapy, the patient’s own T-cells are extracted from the body, modified to recognize and attack cancer cells and re-infused back into the patient. This treatment has shown positive results for patients with lymphoma and lymphoid leukemia and is currently being studied for its potential against myeloid leukemia and multiple myeloma .
  • Our use and refinement of nonmyeloablative (“mini”) transplants, which relies less on the heavy doses of chemotherapy and radiation and more on the anti-cancer effects of the transplant itself. This novel approach allows otherwise ineligible patients, such as older patients or those who cannot tolerate radiation/chemotherapy-related effects, to be treated with this lifesaving procedure.
  • Continual development and improvement of drug regimens to treat hematologic cancers. Recently, City of Hope had led a national study of the drug brentuximab in patients with relapsed Hodgkin lymphoma , in whom the drug produced a high rate of response compared to standard therapy.
  • Our scientists are currently investigating leukemia stem cells, which several studies have suggested to cause leukemia. By identifying and eradicating these cancerous stem cells — instead of just the mature leukemia cells that conventional therapies target — a definitive cure for this disease can be achieved. 
 
 
 
If you have been diagnosed with a hematologic cancer or are looking for a second opinion consultation about your treatment, find out more about becoming a patient or contact us at 800-826-HOPE.
 

Living with a Hematologic Cancer

Living with a Hematologic Cancer

City of Hope patients have access to the broad range of services offered by our Department of Supportive Care Medicine. The department’s staff of professionals can give expert assistance in navigating a complex care as well as helping patients and loved ones with a variety of wellness issues including:
 
  • Managing side effects
  • Pain management
  • Coping and maintaining emotional/social/spiritual well-being
  • Staying healthy and active during/after treatment
  • Guidance on eating well and cooking smart
  • Healing arts
  • Being active
  • Building caregivers’ skills
  • Sexual health and fertility
  • Body image
 
 
The Sheri & Les Biller Patient and Family Resource Center is the heart of the Department of Supportive Care Medicine, integrating City of Hope's support services under one umbrella. The Biller Resource Center provides a warm and welcoming space where patients, families and caregivers can access the resources, education and support they need to strengthen and empower themselves, before, during and after treatment.

Our team of supportive care experts includes clinical social workers; pain and palliative care physicians and nurses; psychologists, psychiatrists; patient navigators; health educators; spiritual care chaplains; child life specialists and more. The Biller Resource Center staff may be reached at 626-256-4673, ext. 32273 (3CARE).
 
 
Here you will find tips, tools and resources to help you and your family cope with the issues that arise during and after cancer treatment.
 
Other Resources
 
"A Patient's Guide to Blood and Marrow Stem Cell Transplantation at City of Hope" was developed to help City of Hope patients and their families learn about blood and marrow transplantation and what to expect before, during and after transplant at City of Hope.
 
 

If you have been diagnosed with a hematologic cancer or are looking for a second opinion consultation about your treatment, find out more about becoming a patient or contact us at 800-826-HOPE.

Transplant Reunion

Celebration of Life Bone Marrow Transplant/HCT Reunion

Bone marrow transplants offer a second chance for people with life-threatening blood cancers and other hematologic malignancies.  City of Hope performed its first bone marrow transplant in 1976. Since then, thousands of patients from virtually every state and dozens of countries have undergone bone marrow, cord blood or stem cell transplants at City of Hope.

City of Hope invites bone marrow transplant recipients and their families to attend the annual “Celebration of Life" event on the Duarte campus. The reunion has grown to more than 6,500 attendees from all over the United States and overseas. The reunion is a joyous day for everyone in attendance — physicians, nurses and former patients — as they celebrate the victories they have attained in fighting cancer. The day also features performances by former patients who entertain their fellow survivors and their families.

The patient-donor meeting is an emotional highlight of the event. Recipients, though overwhelmed with curiosity and the need to express their gratitude, can only dream of meeting the strangers who saved their lives. City of Hope makes that dream come true for two patients every year.

Watch videos, view pictures, read stories and learn more about the Celebration of Life Bone Marrow Transplant Reunion:
 
 
The annual reunion also enables physicians and researchers to advance the science of stem cell transplantation through the sharing of the findings and advances at the Karl G. Blume-Gerhard Schmidt Memorial Lecture held in conjunction with the reunion. The event commemorates the work and dedication of the late Gerhard Schmidt, M.D., who joined City of Hope's hematology program in 1977 and has made numerous contributions to the field throughout this career.
 
 
 
 
 
Quick Links
 
Why City of Hope
Stephen J. Forman, Francis and Kathleen McNamara Distinguished Chair in Hematology and Hematopoietic Cell Transplantation, talks about why City of Hope is a special place for cancer treatment.
 
Hematologic Cancers Support Groups
The focus of the Division of Hematopoietic Stem Cell and Leukemia Research is to improve the understanding of leukemia stem cells in order to develop cures for leukemia and other hematologic malignancies.


NEWS & UPDATES
  • On Jan. 1, 2015, six City of Hope patients who have journeyed through cancer will welcome the new year with their loved ones atop City of Hope’s Tournament of Roses Parade float. The theme of the float is “Made Possible by HOPE.” The theme of the parade is “Inspiring Stories.” Repr...
  • When 25-year-old Angelina Mattos was diagnosed with Stage 4 oral cancer earlier this year, she learned that her only hope of survival was through the removal of her tongue, a surgery that leaves people without the ability to talk or eat normally, sometimes permanently ending their ability to speak. After hearin...
  • Two years ago, Joselyn Miller and her family sat together as stem cells from her brother’s bone marrow were infused into her – a precious gift of life that the family is excited to have the chance to pass to another patient in need. Today, the stem cell recipient is healthy. Her 23-year-old son Rex, who […...
  • Even as the overall rate of oral cancers in the United States steadily declines, the rate of tongue cancer is increasing — especially among white females ages 18 to 44. An oral cancer diagnosis, although rare, is serious. Only half of the people diagnosed with oral cancer are still alive after five years, accor...
  • Sometimes cancer found in the lungs is not lung cancer at all. It can be another type of cancer that originated elsewhere in the body and spread, or metastasized, to the lungs through the bloodstream or lymphatic system. These tumors are called lung metastases, or metastatic cancer to the lungs, and are not the...
  • When it comes to research into the treatment of hematologic cancers, City of Hope scientists stand out. One study that  they presented this week at the annual meeting of the American Society of Hematology suggests a new standard of care for HIV-associated lymphoma, another offers promise for the treatment of re...
  • Patients with HIV-associated lymphoma may soon have increased access to the current standard of care for some non-HIV infected patients – autologous stem cell transplants. Impressive new data, presented Monday at the annual meeting of the American Society of Hematology (ASH) in San Francisco, indicate that HIV-...
  • On Jan. 1, 2015, six City of Hope patients who have journeyed through cancer will welcome the new year with their loved ones atop City of Hope’s Tournament of Roses Parade float. The theme of the float is “Made Possible by HOPE.” The theme of the Rose Parade is “Inspiring Stories.”...
  • The holidays can create an overwhelming urge to give to people in need — especially to sick children and families spending the holidays in a hospital room. That’s a good thing. Holiday donations of toys and gifts can bolster the spirits, and improve the lives, of people affected by illness, and hospitals ...
  • On Jan. 1, 2015, six City of Hope patients who have journeyed through cancer will welcome the new year with their loved ones atop City of Hope’s Tournament of Roses Parade float. The theme of the float is “Made Possible by HOPE.” The theme of the parade is “Inspiring Stories.” Here...
  • Cancer has a way of “talking” to the immune system and corrupting it to work on its own behalf instead of defending the body. Blocking this communication would allow the immune system to see cancer cells for what they are – something to be fought off – and stop them from growing. A breakthrough Scientists [R...
  • On Jan. 1, 2015, six City of Hope patients who have journeyed through cancer will welcome the new year with their loved ones atop City of Hope’s Tournament of Roses Parade float. The theme of the float is “Made Possible by HOPE.” The theme of the parade is “Inspiring Stories.” By V...
  • On Jan. 1, 2015, six City of Hope patients who have journeyed through cancer will welcome the new year with their loved ones atop City of Hope’s Tournament of Roses Parade float. The theme of the float is “Made Possible by HOPE.” The theme of the parade is “Inspiring Stories.” The ...
  • On Jan. 1, 2015, six City of Hope patients who have journeyed through cancer will welcome the new year with their loved ones atop City of Hope’s Tournament of Roses Parade float. The theme of the float is “Made Possible by HOPE.” The theme of the parade is “Inspiring Stories.” In 2...
  • You’ve done the easy stuff – braved the toy store and the Black Friday frenzy, stayed up all night trolling deals online, picked up gift cards for your colleagues at work. There’s just one gift left, the one you’ve been putting off and the one that means so much. What do you give your friend who […]